SCHEMBL381506

SCHEMBL381506

CCOC(=O)OC(=O)CCCCC(=O)OC(=O)OCC

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOAT1 P35610 1/20 0.64
ALDH1A1 P00352 5/20 0.55
CYP1A2 P05177 1/20 0.50
DGKA P23743 1/20 0.45
GAA P10253 2/20 0.44
MGAM O43451 1/20 0.44
SI P14410 1/20 0.44
MGAM2 Q2M2H8 1/20 0.44
CYP4F2 P78329 1/20 0.43
CYP4A11 Q02928 1/20 0.43
TSHR P16473 3/20 0.42
HSD17B10 Q99714 2/20 0.42
ALOX15 P16050 2/20 0.42
CYP3A4 P08684 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
TRPA1 O75762 1/20 0.41
PAM P19021 2/20 0.41
LMNA P02545 1/20 0.40
NR1I2 O75469 1/20 0.40
PGR P06401 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6643452 0.98 SOAT1 (0.61) SOAT1ALDH1A1CYP1A2DGKAGAA
SCHEMBL28005099 0.94 SOAT1 (0.56) SOAT1ALDH1A1CYP1A2DGKAGAA
Hydrochloric Acid SCHEMBL27619222 0.92 SOAT1 (0.54) SOAT1ALDH1A1CYP1A2DGKATSHR
SCHEMBL3327698 0.92 DGKA (0.59) SOAT1ALDH1A1DGKATSHRPAM
SCHEMBL27396784 0.92 DGKA (0.59) SOAT1ALDH1A1DGKATSHRPAM
SCHEMBL6890027 0.92 DGKA (0.59) SOAT1ALDH1A1DGKATSHRPAM
SCHEMBL381507 0.92 SOAT1 (0.54) SOAT1ALDH1A1TSHRHSD17B10ALOX15
SCHEMBL382296 0.92 DGKA (0.59) SOAT1ALDH1A1DGKATSHRPAM
SCHEMBL20503311 0.91 SOAT1 (0.58) SOAT1ALDH1A1CYP1A2DGKAGAA
SCHEMBL6883473 0.90 SOAT1 (0.52) SOAT1ALDH1A1TSHRHSD17B10ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115232058-A Synthesis method of gliclazide intermediate 1,2-cyclopentanedicarboxamide 上海巽田科技股份有限公司 2022-10-25 CN disclosed
US-20120095205-A1 Method of Modification of Hyaluronic Acid by Means of (O-ACYL-O'-ALKYL Carbonate-Substituted Pyridine) Complex CONTIPRO C (CZ) 2012-04-19 US disclosed
EP-2408823-A1 A METHOD OF MODIFICATION OF HYALURONIC ACID BY MEANS OF (O-ACYL-O'-ALKYL CARBONATE - SUBSTITUTED PYRIDINE) COMPLEX Contipro C A.S. (CZ) 2012-01-25 EP disclosed
WO-2010105582-A1 A METHOD OF MODIFICATION OF HYALURONIC ACID BY MEANS OF (O-ACYL-O'-ALKYL CARBONATE - SUBSTITUTED PYRIDINE) COMPLEX CONTIPRO C A.S. (CZ) 2010-09-23 WO disclosed